Tuesday, February 08, 2022 8:49:37 PM
COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER NWB1155367 Printer Friendly Version
Select New Case Application Data Transaction History Image File Wrapper Continuity Data Published Documents Correspondence Data Supplemental Content Assignments Display Download References
Bibliographic Data
Application Number: 14/533,879 Correspondence Address Customer Number: 26389
Filing or 371 (c) Date: 11-05-2014 Status: Non Final Action Mailed
Application Type: Utility Status Date: 08-31-2021
Examiner Name: CANELLA, KAREN A Location: What is a Location? ELECTRONIC
Group Art Unit: 1643 Location Date: -
Confirmation Number: 9311 Earliest Publication No: US 2015-0273033 A1
Attorney Docket Number: NWB1155367 Earliest Publication Date: 10-01-2015
Class / Subclass: 424/130.100 Patent Number: -
First Named Inventor: Marnix Leo Bosch , Clyde Hill, WA (US) all Inventors Issue Date of Patent: -
First Named Applicant: COGNATE BIOSERVICES, INC. , Hanover, MD (US) all Applicants International Registration Number (Hague): -
Entity Status: Small International Registration Publication Date: -
AIA (First Inventor to File): Yes
Title of Invention: COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
Select New Case Application Data Transaction History Image File Wrapper Continuity Data Published Documents Correspondence Data Supplemental Content Assignments Display Download References
Bibliographic Data
Application Number: 14/533,879 Correspondence Address Customer Number: 26389
Filing or 371 (c) Date: 11-05-2014 Status: Non Final Action Mailed
Application Type: Utility Status Date: 08-31-2021
Examiner Name: CANELLA, KAREN A Location: What is a Location? ELECTRONIC
Group Art Unit: 1643 Location Date: -
Confirmation Number: 9311 Earliest Publication No: US 2015-0273033 A1
Attorney Docket Number: NWB1155367 Earliest Publication Date: 10-01-2015
Class / Subclass: 424/130.100 Patent Number: -
First Named Inventor: Marnix Leo Bosch , Clyde Hill, WA (US) all Inventors Issue Date of Patent: -
First Named Applicant: COGNATE BIOSERVICES, INC. , Hanover, MD (US) all Applicants International Registration Number (Hague): -
Entity Status: Small International Registration Publication Date: -
AIA (First Inventor to File): Yes
Title of Invention: COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
